421 related articles for article (PubMed ID: 12915561)
1. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
Bettahi I; Zhang X; Afifi RE; BenMohamed L
Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
[TBL] [Abstract][Full Text] [Related]
4. A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.
Goel N; Rong Q; Zimmerman D; Rosenthal KS
Vaccine; 2003 Oct; 21(27-30):4410-20. PubMed ID: 14505924
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
6. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.
Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097
[TBL] [Abstract][Full Text] [Related]
7. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.
Wang X; Xie G; Liao J; Yin D; Guan W; Pan M; Li J; Li Y
Virol J; 2011 May; 8():232. PubMed ID: 21575169
[TBL] [Abstract][Full Text] [Related]
9. J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.
Taylor PR; Koski GK; Paustian CC; Bailey E; Cohen PA; Moore FB; Zimmerman DH; Rosenthal KS
Vaccine; 2010 Aug; 28(34):5533-42. PubMed ID: 20600501
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.
Li X; Zhang S; Lei J; Zhu Y; Zhou X; Xiao J; Xiang T
Int Immunopharmacol; 2018 Aug; 61():100-108. PubMed ID: 29857239
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection.
Nass PH; Elkins KL; Weir JP
Vaccine; 2001 Jan; 19(11-12):1538-46. PubMed ID: 11163680
[TBL] [Abstract][Full Text] [Related]
12. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
Chentoufi AA; Zhang X; Lamberth K; Dasgupta G; Bettahi I; Nguyen A; Wu M; Zhu X; Mohebbi A; Buus S; Wechsler SL; Nesburn AB; BenMohamed L
J Immunol; 2008 Jan; 180(1):426-37. PubMed ID: 18097044
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
14. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
15. Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.
Zhang X; Castelli FA; Zhu X; Wu M; Maillère B; BenMohamed L
Clin Vaccine Immunol; 2008 Sep; 15(9):1436-49. PubMed ID: 18667634
[TBL] [Abstract][Full Text] [Related]
16. Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.
Gierynska M; Kumaraguru U; Eo SK; Lee S; Krieg A; Rouse BT
J Virol; 2002 Jul; 76(13):6568-76. PubMed ID: 12050369
[TBL] [Abstract][Full Text] [Related]
17. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
[TBL] [Abstract][Full Text] [Related]
18. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
19. Identification of a herpes B virus-specific glycoprotein d immunodominant epitope recognized by natural and foreign hosts.
Perelygina L; Zurkuhlen H; Patrusheva I; Hilliard JK
J Infect Dis; 2002 Aug; 186(4):453-61. PubMed ID: 12195371
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B.
Chentoufi AA; Binder NR; Berka N; Durand G; Nguyen A; Bettahi I; Maillère B; BenMohamed L
J Virol; 2008 Dec; 82(23):11792-802. PubMed ID: 18799581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
